📊 End of Day Bhavcopy
Date: 2025-09-09
Price: 88.71
% Change: -0.33% (Prev Close: 89.00)
Volume: 10,255
% Change: -53.31% (Prev Volume: 21,965)
Delivery: 6,556
Delivery % : 63.93
% Change: -51.21% (Prev Delivery: 13,436)
Turnover: 9 Lacs
% Change: -52.99% (Prev Turnover: 19)
💹 EOD Valuation
P/E Ratio: 19.71
P/B Ratio: 1.82
Market Cap: 141 Rs. Cr.
Fundamental Data
Date: 05-09-2025
🏷️ Company Basics
Symbol: BALPHARMA
Market Cap: 138 Rs. Cr.
Face Value: 10.00 Rs.
52 Week High: 142.70
52 Week Low: 76.30
All-Time High: 167.90 Rs.
All-Time Low: 13.15 Rs.
Stock Price Increase (% Return) %
% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-7.30% | -11.00% | 4.07% | -35.52% | -2.19%
👥 Shareholding Pattern
Promoter Holding
Promoter Holding: 50.86%
Change (3Y | 1Y): -1.14% | 0.00%
Pledged %: 0.00%
FII Holding
FII Holding: 0.15%
Change (3Y | 1Y): -0.15% | 0.01%
DII Holding
DII Holding: 0.00%
Change (3Y | 1Y): 0.00% | 0.00%
Public Holding: 48.99%
🏦 Financial Strength
Debt to Equity: 1.94
Debt: 150.41 Rs. Cr.
Book Value: 48.63 Rs.
Current Ratio: 1.07
Interest Coverage: 1.28
Free Cash Flow: 1.53 Rs. Cr.
📈 Growth & Sales
Sales Growth: -14.16%
Sales Growth Qtr (YOY | QoQ):
-11.42% | -19.55%
Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
12.12% | 2.53% | -14.16%
💰 Profit & Earnings
Profit Growth %
Profit Growth: -5.42%
Profit Growth Qtr (YOY | QoQ):
-19.23% | -96.12%
Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
20.95% | 13.10% | -5.42%
EPS Rs.
EPS (TTM): 4.50 Rs.
EPS Qtr (Last Year | Latest):
0.16 Rs. | 0.13 Rs.
EPS Annual (Last Annual | Annual March):
4.68 Rs. | 4.53 Rs.
EPS Growth Variation % (5 Yrs | 3 Yrs):
20.34% | 10.44%
Net Profit Rs. Cr.
Net Profit (TTM): 7.18 Rs. Cr.
Net Profit (Annual - March): 7.24 Rs. Cr.
Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
0.26| 5.41 | 0.21
EBITDA Rs. Cr.
EBITDA (Quarter): 6.78 Rs. Cr.
EBITDA (Previous Yr Ql): 7.29 Rs. Cr.
EBITDA (Annual - March): 31.76 Rs. Cr.
EBITDA (Previous Annual): 34.48 Rs. Cr.
EBITDA (5 Yrs | 3 Yrs) %:
35.99% | 4.41%
📊 Profitability Ratios
Operating Margin (OPM)
OPM (TTM): 9.89%
OPM Qtr (Previous | Current):
9.33% | 9.20%
OPM Annual (5 Yrs | Last Yr | March):
9.14% | 9.35% | 9.75%
Return on Equity %
ROE: 9.84%
ROE (5 Yrs | 3 Yrs | Last Yr):
8.65% | 8.51% | 11.03%
Return on Capital Employed %
ROCE: 10.07%
ROCE (5 Yrs | 3 Yrs | Last Yr):
10.64% | 10.57% | 12.10%
Return on Assets %
ROA (TTM): 2.22%
ROA (5 Yrs | 3 Yrs | Last Yr):
1.89% | 1.83% | 2.35%
PEG Ratio: 1.47
Dividend Yield: 1.38%
PE 3 Yrs: 36.08
PE 5 Yrs: 27.27
Dividend Yield: 1.38%
👥 Company
Bal Pharma Ltd
BALPHARMA
Promoter Holding: %